Trenzyme receives ISO 9001 certification
"This certification sets us apart from most of our competitors, especially in such complex areas as cell line development and protein expression offering such a variety of host systems." says the founder and CEO Dr. Reinhold Horlacher. "The newly enhanced and completely electronical quality management system is instrumental to a flawless process documentation and an efficient corporate management. It guarantees that our products adhere a consistently high standard which our customers expect from us."
Under guidance of Trenzyme's Co-CEO Konstantin Matentzoglu the Konstanz (Germany)-based company also developed a comprehensive range of cell biological services, including Trenzyme's ExoIN cell line development technology. ExoIN makes it possible to generate homogenous, stable expression cell lines in a record-setting two weeks.
"The expansion of our cell culture business unit gives our customers the ability to choose any of the relevant expression-host systems. Depending on the customer's needs, we are able to generate any expression system: from bacteria and yeast to insect and mammalian cells. It has become one of our core strengths to be able to offer the complete range of services from strain and cell line development over protein expression and protein purification to analytics." explains the Co-CEO Konstantin Matentzoglu.
Topics
Organizations
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.